Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A plea for a randomized controlled trial
- PMID: 36162523
- DOI: 10.1016/j.ijcard.2022.09.045
Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A plea for a randomized controlled trial
Abstract
Background: Current guidelines do not recommend screening for asymptomatic carotid artery stenosis (AsxCS). The rationale behind this recommendation is that detection of AsxCS may lead to an unnecessary carotid intervention. In contrast, screening for abdominal aortic aneurysms is strongly recommended.
Methods: A critical analysis of the literature was performed to evaluate the implications of detecting AsxCS.
Results: Patients with AsxCS are at high risk for future stroke, myocardial infarction and vascular death. Population-wide screening for AsxCS should not be recommended. Additionally, screening of high-risk individuals for AsxCS with the purpose of identifying candidates for a carotid intervention is inappropriate. Instead, selective screening for AsxCS should be considered and should be viewed as an opportunity to identify individuals at high risk for atherosclerotic cardiovascular disease and future cardiovascular events for the timely initiation of intensive medical therapy and risk factor modification.
Conclusions: Although mass screening should not be recommended, there are several arguments suggesting that selective screening for AsxCS should be considered. The rationale supporting such selective screening is to optimize risk factor control and to initiate intensive medical therapy for prevention of future cardiovascular events, rather than to identify candidates for an intervention.
Keywords: Asymptomatic carotid atherosclerosis; Carotid plaque burden; Carotid stenosis; Guidelines; Screening; Stroke.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest All authors are members of the Faculty Advocating Collaborative and Thoughtful Carotid Artery Treatments (FACTCATS; available at www.FACTCATS.org) with the shared goal of optimizing stroke prevention. The views of particular FACTCATS do not necessarily reflect the views of other FACTCATS.
Comment in
-
Screening for asymptomatic carotid stenosis in patients with non-valvular atrial fibrillation.Int J Cardiol. 2023 Feb 1;372:120-121. doi: 10.1016/j.ijcard.2022.11.037. Epub 2022 Nov 23. Int J Cardiol. 2023. PMID: 36435330 No abstract available.
-
Could carotid screening cause more harm than good?Int J Cardiol. 2023 Mar 1;374:115. doi: 10.1016/j.ijcard.2022.12.038. Epub 2022 Dec 21. Int J Cardiol. 2023. PMID: 36565955 No abstract available.
-
Clarifying the rationale supporting selective screening for asymptomatic carotid artery stenosis.Int J Cardiol. 2023 Apr 1;376:174-175. doi: 10.1016/j.ijcard.2023.01.028. Epub 2023 Jan 18. Int J Cardiol. 2023. PMID: 36681248 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical